₹2,816.9
▲ +110.42 +4.08%
17 Jul 2026
NSE Listed
Kwality Pharmaceuticals Limited (KPL)
Volume: 31,108Avg Vol 1W: 19,348.6Avg Vol 1M: 32,219.6552W Range:₹1,561₹2,890.3
Key Ratios
Checked 18h agoMarket Cap₹2,808 Cr
Current Price₹2,816.9
Previous Close₹2,706.48
High / Low (52w)₹2,890.3 / ₹1,561
Volume31,108
Avg Vol (1W)19,348.6
Avg Vol (1M)32,219.65
Stock P/E41.32
Book Value₹319.46
Dividend Yield0%
ROE20.31%
ROA11.37%
Revenue (TTM)₹372 Cr
Revenue Growth—
Profit Margin13.39%
Total Debt—
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹24.39
P/B8.5
Debt / Equity0.43
50 DMA₹2,386.85
200 DMA₹2,209.42
Day change+4.08%
Price Chart
₹2,816.9▲ 69.43% · 1Y
2026-04-202026-07-15
20-day avg volume: 32K shares
Pros
- Healthy return on equity of 20.3%.
- Company is almost debt-free.
Cons
- Revenue fell 17% YoY.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹80 Cr | ₹90 Cr | ₹84 Cr | ₹116 Cr | ₹111 Cr | ₹111 Cr | ₹123 Cr | ₹157 Cr |
| EBITDA | ₹14 Cr | ₹15 Cr | ₹14 Cr | ₹22 Cr | ₹20 Cr | ₹21 Cr | ₹26 Cr | ₹35 Cr |
| Net Profit | ₹8 Cr | ₹8 Cr | ₹9 Cr | ₹14 Cr | ₹12 Cr | ₹14 Cr | ₹16 Cr | ₹25 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹138 Cr | ₹167 Cr | ₹143 Cr | ₹264 Cr | ₹460 Cr | ₹254 Cr | ₹309 Cr | ₹372 Cr |
| EBITDA | ₹9 Cr | ₹13 Cr | ₹13 Cr | ₹24 Cr | ₹164 Cr | ₹48 Cr | ₹49 Cr | ₹64 Cr |
| Net Profit | ₹5 Cr | ₹8 Cr | ₹8 Cr | ₹15 Cr | ₹120 Cr | ₹19 Cr | ₹24 Cr | ₹40 Cr |
| EPS | 4.38 | 7.28 | 8.02 | 14.6 | 115.12 | 18.16 | 22.76 | 38.36 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹96 Cr | ₹105 Cr | ₹133 Cr | ₹166 Cr | ₹341 Cr | ₹354 Cr | ₹394 Cr | ₹447 Cr |
| Total Liabilities | ₹67 Cr | ₹69 Cr | ₹88 Cr | ₹106 Cr | ₹161 Cr | ₹155 Cr | ₹172 Cr | ₹185 Cr |
| Equity | ₹29 Cr | ₹36 Cr | ₹45 Cr | ₹60 Cr | ₹180 Cr | ₹199 Cr | ₹223 Cr | ₹262 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹2 Cr | ₹17 Cr | ₹9 Cr | ₹33 Cr | ₹102 Cr | ₹48 Cr | ₹44 Cr | ₹69 Cr |
| Investing | ₹-6 Cr | ₹-12 Cr | ₹-18 Cr | ₹-23 Cr | ₹-63 Cr | ₹-48 Cr | ₹-26 Cr | ₹-29 Cr |
| Financing | ₹5 Cr | ₹-2 Cr | ₹12 Cr | ₹1 Cr | ₹6 Cr | ₹1 Cr | ₹-17 Cr | ₹-14 Cr |
| Free Cash Flow | ₹2 Cr | ₹17 Cr | ₹9 Cr | ₹33 Cr | ₹102 Cr | ₹48 Cr | ₹44 Cr | ₹69 Cr |
Shareholding
Promoter 54.87% Institutions 3.15% Public 41.98%
Efficiency & Working Capital
ROCE21.5%
Interest Coverage6.5
Dividend Payout—
Debtor Days152 d
Inventory Days82 d
Payable Days55 d
Cash Conversion Cycle179 d
Working Capital Days234 d
Shareholding Details
As of 2026-03-31
Promoter54.9%
FII2.8%
DII0.4%
Institutions3.1%
Public42%
Promoter Pledge0%
No. of Shareholders10,555
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 54.7% | 54.8% | 54.8% | 54.8% | 54.8% | 54.8% | 54.8% | 54.8% | 54.8% | 54.8% | 54.8% | 54.9% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.5% | 2.8% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% |
| Public | 45.3% | 45.2% | 45.2% | 45.2% | 45.2% | 45.2% | 45.1% | 44.9% | 44.8% | 44.8% | 44.3% | 42% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 6,943 | 6,291 | 5,786 | 5,695 | 5,273 | 7,487 | 8,947 | 9,420 | 10,115 | 11,595 | 10,709 | 10,555 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Ramesh Arora | Shareholding of Promoter and Promoter Group | 26% | 27,00,632 |
| Ajay Arora | Shareholding of Promoter and Promoter Group | 13.6% | 14,11,579 |
| Aditya Arora | Shareholding of Promoter and Promoter Group | 12% | 12,41,039 |
| Deepak Bansal | Public Shareholding | 9.2% | 9,58,746 |
| Manohar Devabhaktuni | Public Shareholding | 5% | 5,16,735 |
| Ark Global Emerging Companies, Lp | Public Shareholding | 2.1% | 2,18,896 |
| Kadayam Ramnathan Bharat | Public Shareholding | 2% | 2,05,000 |
| Dheeraj Kumar Lohia | Public Shareholding | 1.9% | 1,93,358 |
| Jani Bhasha Shaik | Public Shareholding | 1.5% | 1,50,000 |
| Anju Arora | Shareholding of Promoter and Promoter Group | 1.3% | 1,35,634 |
| Onkar Singh | Public Shareholding | 1.1% | 1,13,200 |
| Geeta Arora | Shareholding of Promoter and Promoter Group | 1.1% | 1,11,500 |
| Jugal Kishore Huf | Shareholding of Promoter and Promoter Group | 0.9% | 92,350 |
| Aarti Bajaj | Shareholding of Promoter and Promoter Group | 0% | 125 |
| Sachin Seth | Shareholding of Promoter and Promoter Group | 0% | 210 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Ajay Arora | 0 | 0% | 2026-03-31 |
| Ramesh Arora | 0 | 0% | 2026-03-31 |
| Jugal Kishore Huf | 0 | 0% | 2026-03-31 |
| Anju Arora | 0 | 0% | 2026-03-31 |
| Geeta Arora | 0 | 0% | 2026-03-31 |
| Aarti Bajaj | 0 | 0% | 2026-03-31 |
| Sachin Seth | 0 | 0% | 2026-03-31 |
| Aditya Arora | 0 | 0% | 2026-03-31 |
| Ark Global Emerging Companies, Lp | 0 | 0% | 2026-03-31 |
| Kadayam Ramnathan Bharat | 0 | 0% | 2026-03-31 |
| Deepak Bansal | 0 | 0% | 2026-03-31 |
| Onkar Singh | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Ramesh Arora | Executive Director & MD | 2025 |
| Ajay Arora | E D & Wholetime Director | 2025 |
| Aditya Arora | Executive Director / Whole Time Director / CFO | 2025 |
| Geeta Arora | E D & Wholetime Director | 2025 |
| Anju Arora | E D & Wholetime Director | 2025 |
| Kartik Kapur | Independent Non Exe. Director | 2025 |
| Prashanth Vellanki | Independent Non Exe. Director | 2025 |
| Vinod Kumar Sharma | Independent Non Exe. Director | 2025 |
| Gurpreet Kaur | Company Sec. & Compli. Officer | 2025 |
| Bhavesh Mahajan | Independent Non Exe. Director | 2025 |
| Preet Mohinder S Bedi | Independent Non Exe. Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceuticals | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Export | ₹195 Cr | 52.8% |
| Domestic | ₹175 Cr | 47.2% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 16 | 10 | 10 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 5 | 0 | 0 | 3 | 0 | 8 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 5 | 0 | 0 | 3 | 0 | 8 |
Insider / Designated-Person Trades
29 recent disclosure(s)
Aastha SethAcquisition · 1,000
RAMESH KUMARAcquisition · 1,948
AJAY KUMAR ARORAAcquisition · 941
ADITYA ARORAAcquisition · 948
ADITYA ARORAAcquisition · 4,919
ADITYA ARORAAcquisition · 3,200
Substantial Acquisitions (SAST)
6 disclosure(s)
Market16/02/2024 · 1,200
Market15/02/2024 · 4,919
Market30/06/2023 · 1,04,000
-27/06/2023 · 5,18,810
Market24/05/2023 - 08/06/2023 · 3,02,000
NULL15/12/2021 · 25,620
Company Information
🌐 www.kwalitypharma.com ↗
📍 Village Nagkalan, Majitha Road, Amritsar, Punjab, 143601
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search